Immune to Cancer: The CRI Blog
-
ImmunoAdvocate Perspectives: Navigating Cancer Immunotherapy and Survivorship
Sharing one’s cancer survival story is not just a personal act of courage — it has the… -
Journey Through the Highlights of the 12th Annual Cancer Immunotherapy Month™
Each June, CRI invites its global community of scientists, caretakers, patients, and more to take part in… -
FDA approves EPKINLY® for relapsed or refractory follicular lymphoma
June 26, 2024, marked a milestone for patients suffering from follicular lymphoma. The FDA approved Genmab’s epcoritamab-bysp… -
What’s in Your Glass? Weighing the Health Risks of Alcohol Consumption
“Just one for the road.” We’ve all heard or said this at a party. Alcohol is a… -
CRI’s 5th Annual Wear White Luncheon Raises Over $40,000
On Thursday, June 20, 2024, the Cancer Research Institute (CRI) celebrated its fifth annual Wear White Luncheon,… -
Keytruda Receives 40th FDA Approval
This week marked a significant milestone in the fight against cancer. On June 17, the FDA approved… -
#Immune2Cancer Day Ignites Support for CRI
The cornerstone of Cancer Immunotherapy MonthTM is #Immune2Cancer Day, June 14, a day dedicated to showcasing the… -
Exploring the Different Types of Cancer and Treatment Options
Cancer is a formidable adversary, but our understanding of this disease has come a long way. Cancer… -
Rising Female Talents in Cancer Immunotherapy Research
In recent years, there has been a renewed and welcomed focus on female scientists in STEM (science,…